Cure My Disease

Don't miss your cure!

 Log in / Sign up

Brain zaps may offer temporary swallowing relief for stroke patients

NCT ID NCT06305949

Symptom relief Sponsor: NEUROPHET Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests if a safe, non-invasive brain stimulation technique called transcranial direct current stimulation (tDCS) can temporarily improve swallowing in people who have trouble swallowing after a stroke. About 30 adults who had a first stroke at least 3 weeks ago will receive either real or fake (sham) stimulation. Researchers will measure changes in swallowing ability using standard scales.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2024

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * men and women \>19 years old * patients with stroke confirmed by neuroimaging * first-time stroke patients * patients in subacute or chronic phases of stroke with 3 weeks or more after onset * stroke patients with confirmed dysphagia through Videofluoroscopic Swallowing Study (VFSS). Exclusion Criteria: * patients with recurrent stoke, traumatic brain injury, spine cord injury, and degenerative brain disease, such as Parkinson's disease, etc. * patients with deteriorated cognitive function unable to perform the clinical trial as instructed * patients with evidence of delirium, confusion, or other impairment of consciousness * patients with uncontrolled medical disease or surgical conditions * patients ineligible for Transcranial direct current stimulation (due to scalp condition, metallic material at the electrode attachment area, presence of a pacemaker or cochlear implant) * patients with previous experience within the last year using a stimulation device similar to the one use in this clinical trial or who have participated in related clinical trials * patients with severe neurologic disorder with concomitant major psychiatric disorder such as major depressive disorder and dementia * patients with history of uncontrolled epilepsy within 6 months * patients with medical contraindications for neuroimaging test, such as MRI; * patients who are taken contraindicated medications or require medication changes during the trial period that could influence cognitive/motor function changes via brain activation changes * patients who are pregnant, breastfeeding, or planning pregnancy during the trial period * patients considered medically ineligible for participation in the present trial beyond the criteria listened above.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Deglutition disorders are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Deglutition Disorders

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Deglutition disorders

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • The Catholic University of Korea, Bucheon St. Mary's Hospital

    RECRUITING

    Bucheon-si, 14647, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.